Rizwana F. Sproule, VP Regulatory Affairs at Kite Pharma, Inc. (KITE), sold 9,567 shares at $60.21 ($582K) on 2015-08-17, disclosed to the SEC on 2015-08-19.
Scheduled sale ($582k) by VP Regulatory Affairs under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $60.21 | 2,780 | $167K | 28.7% |
| 2 | $60.99 | 5,322 | $325K | 55.7% |
| 3 | $61.73 | 1,465 | $90K | 15.5% |
| Total | $60.88 avg | 9,567 | $582K | 100% |
| Filing → |
| KITE | SELL | 2016-01-19 | $531K | — | Filing → |
| KITE | SELL | 2015-12-17 | $610K | — | Filing → |
| KITE | SELL | 2015-11-18 | $748K | — | Filing → |